Sackler family to pay as much as $6B in new opioid settlement with U.S. states
Members of the Sackler family and their company Purdue Pharma, maker of OxyContin, have reached a new settlement with U.S. states, bringing an end to litigation surrounding the company's role in the country's opioid epidemic, Axios reports.
In December, an earlier settlement was rejected by a federal judge following objections from eight states and Washington, D.C., whose attorneys general worried the deal didn't do enough to hold the Sackler family accountable, The Associated Press and Axios report.
The holdouts — California, Connecticut, Delaware, Maryland, Oregon, Rhode Island, Vermont, Washington, and the District of Columbia — on Thursday agreed to a new deal after the Sacklers agreed to throw in more cash and accepted other terms, AP writes, noting that, "the family would be protected from civil lawsuits" (and not criminal ones) in exchange.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The settlement opens "the way for billions of dollars to begin flowing to addiction treatment programs nationwide," writes The New York Times; should a judge ultimately approve the agreement, "the Sacklers will pay as much as $6 billion to help communities address the damages wrought by the opioid crisis."
Though the family did not explicitly apologize or accept any personal wrongdoing for the epidemic, they did issue a somewhat-regretful statement regarding the settlement, AP notes.
"The families have consistently affirmed that settlement is by far the best way to help solve a serious and complex public health crisis. While the families have acted lawfully in all respects, they sincerely regret that OxyContin, a prescription medicine that continues to help people suffering from chronic pain, unexpectedly became part of an opioid crisis that has brought grief and loss to far too many families and communities," the statement reads.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
A growing iodine deficiency could bring back America's goiter
Under the Radar Ailment is back thanks to complacency, changing diets and a lack of public-health education
By Harriet Marsden, The Week UK Published
-
Today's political cartoons - November 10, 2024
Cartoons Sunday's cartoons - civic duty, uncertain waters, and more
By The Week US Published
-
5 ladylike cartoons about women's role in the election
Cartoons Artists take on the political gender gap, Lady Liberty, and more
By The Week US Published
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstances
Speed Read
By Peter Weber Published
-
Western mountain climbers allegedly left Pakistani porter to die on K2
Speed Read
By Justin Klawans Published
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governor
Speed Read
By Peter Weber Published
-
Los Angeles city workers stage 1-day walkout over labor conditions
Speed Read
By Justin Klawans Published
-
Mega Millions jackpot climbs to an estimated $1.55 billion
Speed Read
By Catherine Garcia Published
-
Bangladesh dealing with worst dengue fever outbreak on record
Speed Read
By Catherine Garcia Published
-
Glacial outburst flooding in Juneau destroys homes
Speed Read
By Catherine Garcia Published
-
Scotland seeking 'monster hunters' to search for fabled Loch Ness creature
Speed Read
By Justin Klawans Published